Forward Industries transferred 1.727 million SOL tokens, worth $219.32 million, to a wallet address.

- ECB warns U.S. equity/crypto corrections threaten stability, urging central banks to retain rate-cut flexibility amid market volatility. - JPMorgan links crypto ETF outflows to retail investor behavior, noting $4B November sales contrast with $96B equity ETF inflows. - U.S. Treasury downplays recession risks, citing 2026 growth optimism despite shutdown impacts and services-driven inflation. - MSCI highlights tech valuation risks akin to dot-com era, while DeFi faces $12B liquidity crisis with 95% capita

- Novartis raised 2030 sales growth targets to 5-6% annually, driven by high peak sales expectations for oncology drugs Kisqali and Scemblix. - CEO Vas Narasimhan highlighted eight de-risked drugs with $3-10B peak potential, but analysts warned of patent expirations and uncertain pipeline progress beyond 2030. - Shares rose 0.5% post-announcement, while Exact Sciences surged 17% on its $105/share acquisition by Abbott and Samsung Biologics saw a 71% valuation re-rating after spin-off. - J.P. Morgan caution

- Blockdaemon's Institutional Vault now supports Canton Coin, enabling secure custody and tokenization for institutions on the Canton Network. - 21shares launched a Canton Coin ETP on Euronext, offering investors institutional-grade exposure to privacy-focused blockchain innovation. - Canton Network's architecture, backed by J.P. Morgan and Goldman Sachs , facilitates secure, interoperable transactions while maintaining regulatory compliance. - Partnerships between blockchain infrastructure providers and t